Fonotracetam is a nootropic drug,has a pronounced antiamnestic effect, has a direct activating effect on the integrative activity of the brain, promotes memory consolidation, improves concentration of attention and mental activity, facilitates the learning process, increases the speed of information transfer between hemispheres of the brain, increases the resistance of brain tissues to hypoxia and toxic effects, possesses anticonvulsant action and anxiolytic activity, regulates the processes of activation and inhibition of the central nervous system th system (CNS), improves mood.
Fonturacetam has a positive effect on the metabolic processes and blood circulation of the brain, stimulates redox processes, increases the energy potential of the body through the utilization of glucose, improves regional blood flow in the ischemic areas of the brain. Increases the content of norepinephrine, dopamine and serotonin in the brain, does not affect the level of content γ-aminobutyric acid (GABA), does not bind to either GABAA, nor with GABAAT receptors, does not have a significant effect on the spontaneous bioelectrical activity of the brain.
Fonotracetam has no effect on respiration and cardiovascular system, shows an unexpressed diuretic effect, has anorexigenic activity in course use.
The stimulating effect of fonetracetam is manifested in its ability to exert a moderately pronounced effect on motor responses, in increasing physical performance, in pronounced antagonism to the catalepytic action of neuroleptics, and also in weakening the expression of the hypnotics of ethanol and hexenal. The psychostimulatory effect of fonotracetam predominates in the ideator sphere.
Moderate psychostimulant effect of the drug is combined with anxiolytic activity, improves mood, has some analgesic effect, increasing the threshold of pain sensitivity.
Adaptogenic action of fonetracetam is manifested in increasing the body's resistance to stress in conditions of excessive mental and physical stress, fatigue, hypokinesia and immobilization, at low temperatures.
Against the background of reception of fonotracetam, improvement in vision is noted, which is manifested in an increase in acuity, brightness and fields of vision.
Fonturacetam improves the blood supply of the lower extremities.
Fonturacetam stimulates the production of antibodies in response to antigen administration, which indicates its immunostimulatory properties, but at the same time it does not promote the development of immediate type hypersensitivity and does not change the allergic inflammatory skin reaction caused by the introduction of a foreign protein.
With the course of administration of fonuracetam, drug dependence, tolerance, and withdrawal syndrome do not develop.
The action of fonetracetam appears with a single dose, which is important when the drug is used in extreme conditions.
Fonotracetam does not have teratogenic, mutagenic, carcinogenic and embryotoxic properties. Toxicity is low, the lethal dose in an acute experiment is 800 mg / kg.